ConductScience.org, home

Gene · 3642

INSM1: INSM transcriptional repressor 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. INSM1: INSM transcriptional repressor 1. Genes, record 3642. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3642

On this page

Gene

Symbol
INSM1
HGNC
Name
INSM transcriptional repressor 1
HGNC
NCBI Gene ID
3642
NCBI Gene
HGNC ID
HGNC:6090
HGNC
Ensembl
ENSG00000173404
NCBI Gene
Aliases
IA-1, IA1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q01101Insulinoma-associated protein 15105Ensembl, GeneID, HGNC

Source UniProt

Patents22

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1449930Q01101Espacenet
JP 2025147176 A2025-10-0615167Q01101Espacenet
EP 4590323 A22025-07-3062Q01101Espacenet
JP 2025028160 A2025-02-2815167Q01101Espacenet
KR 1020250010750 A2025-01-2115167Q01101Espacenet
JP 2024109657 A2024-08-1415006Q01101Espacenet
US 11446398 B22022-09-2040624Q01101Espacenet
JP 2022524081 A2022-04-27143595Q01101Espacenet
JP 2021536249 A2021-12-2715360Q01101Espacenet
US 11078247 B22021-08-035529Q01101Espacenet

1 to 10 of 22

See all 22 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants741

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleINSM1 papersNewest fiscal year
P30CA008748Cancer Center Support Grant362025
P50CA097186The Pacific Northwest Prostate Cancer SPORE152025
U24CA213274Coordinating center for the NCI small cell lung cancer research consortium122025
P01CA163227Androgen Receptor Action in Castration Resistant Prostate Cancer82025
R37CA241486Molecular mechanisms underlying lineage plasticity in prostate cancer82025
P30CA015704Cancer Center Support Grant62025
R01CA266452Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity62025
P30CA086862Cancer Center Support Grant52025
P50CA186786Michigan Prostate SPORE 2025-203052025
ZIABC011793Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies52025

1 to 10 of 741Source NIH's project files

See all 741 nih grants

Papers1,406

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Early Recurrence of Non-neuroendocrine Primary Cutaneous Mucinous Carcinoma of the Eyelid After Surgical Excision: A Case Report.Cureus202642802765PubTator, text miningPubMed
Contralateral Primary Small-Cell Neuroendocrine Carcinoma of the Breast With Focal Squamous Differentiation in a Patient With Prior Invasive Ductal Carcinoma: A Rare Case.Cureus202642787006PubTator, text miningPubMed
Uterine Tumor Resembling Ovarian Sex Cord Tumor With GREB1::NCOA2 Fusion and Neuroendocrine Marker Expression: A Case Report and Literature Review.Int J Surg Pathol202642770431PubTator, text miningPubMed
Bladder Large Cell Neuroendocrine Carcinoma(LCNEC): A Case Report of Exfoliated Cytology and Pathological Characteristics.J Vis Exp202642762149PubTator, text miningPubMed
Molecular Subtyping of Biliary Tract Neuroendocrine Carcinomas: Clinicopathological Features and Prognostic Implications.Am J Surg Pathol202642733321PubTator, text miningPubMed
First Case of Mixed Poorly Differentiated Mucinous Adenocarcinoma and High-Grade Neuroendocrine Neoplasm With Amphicrine Differentiation.Cureus202642732443PubTator, text miningPubMed
Neuroendocrine Differentiation in Synovial Sarcoma-An Immunohistochemical Study of 357 Tumors With 4 Markers: Chromogranin A, Synaptophysin, Insulinoma-associated Protein 1 and Insulin Gene Enhancer Protein ISL-1.
Appl Immunohistochem Mol Morphol202642720542PubTator, text miningPubMed
Case Report: Hidden danger in breast eczematous lesions: cutaneous metastasis from silent lung adenocarcinoma misdiagnosed as Paget's disease.Front Oncol202642688082PubTator, text miningPubMed
TTF-1-Positive Merkel Cell Carcinoma in Situ: Extending the Neoplasm's Immunophenotypic Spectrum Through Case Study and Literature Review.J Cutan Pathol202642674577PubTator, text miningPubMed
Primary ovarian non-small cell neuroendocrine carcinoma in an adolescent: The youngest case reported to date.Pathol Res Pract202642659772PubTator, text miningPubMed

1 to 10 of 1,406

See all 1,406 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/3642

GET https://conductscience.org/api/genes/v1/3642/patents?page=2